Board Of Trustees Of The Leland Stanford Junior University Foghorn Therapeutics Inc. Transaction History

Board Of Trustees Of The Leland Stanford Junior University

$1.17 Billion
Q3 2024

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q2 2021 Aug 16, 2021	SELL	$9.32 - $13.26 $285,723 - $406,511	-30,657 Closed	0 $0
Q4 2020 Feb 10, 2021	BUY	$15.12 - $25.88 $463,533 - $793,403	30,657 New	30,657 $621,000

Others Institutions Holding FHTX

# of Institutions

Shares Held

33.4M

Call Options Held

8.7K

Put Options Held

2.4K

Flagship Pioneering Inc. Cambridge, MA

12.7M
Shares

$53.1 Million
20.03% of portfolio
Bvf Inc San Francisco, CA

5.3M
Shares

$22.2 Million
1.57% of portfolio
Deerfield Management Company, L.P. (Series C) New York, NY

3.03M
Shares

$12.7 Million
0.52% of portfolio
Raymond James & Associates St Petersburg, FL

2.3M
Shares

$9.63 Million
0.01% of portfolio
Vanguard Group Inc Valley Forge, PA

1.73M
Shares

$7.26 Million
0.0% of portfolio

View Full List

About Foghorn Therapeutics Inc.

Ticker FHTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,637,400
Market Cap $174M
Description
Foghorn Therapeutics Inc., a clinical-stage biopharmaceutical company, discovers and develops medicines targeting genetically determined dependencies within the chromatin regulatory system. The company uses its proprietary Gene Traffic Control platform to identify, validate, and potentially drug targets within the system. It is developing FHD-28...

More about FHTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Board Of Trustees Of The Leland Stanford Junior University, based on Form 13F filings with the SEC.

News

Stay updated on Board Of Trustees Of The Leland Stanford Junior University with notifications on news.

Account